Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia

Abstract

To study the expression and significance of the serine protease Omi/HtrA2 in prostate cancer and benign prostatic hyperplasia. The expression of Omi/HtrA2 was assayed by means of immunohistochemical technique in 41 prostate cancer (Cap), 20 benign prostatic hyperplasia (BPH) and 10 normal prostate (NP) specimens. Omi/HtrA2 expression was positive in 30 (73.17%) prostate cancer specimens, and the positive rate of Omi/HtrA2 was lower in well differentiated than in poorly and moderately differentiated groups (P<0.05). By contrast, the cells in normal prostate and benign prostatic hyperplasia groups showed no or weak expression of Omi/HtrA2. Prostate cancer cells in vivo may need Omi/HtrA2 expression for apoptosis, and that Omi/HtrA2 expression might be involved in prostate cancer development.

Keywords

Omi/HtrA2 / serine protease / prostate cancer / benign prostatic hyperplasia / apoptosis

References

[1] VerhagenA M, SilkeJ, EkertP G, et al. . HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem, 2002, 277: 445-445

[2] YooN J, KimH S, KimS Y, et al. . Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas. APMIS, 2003, 111: 382-382

[3] SuzukiY, Takahashi-NikiK, AkagiT, et al. . Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ, 2004, 11: 208-208

[4] HegdeR, SrinivasulaS M, ZhangZ, et al. . Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem, 2002, 277: 432-432

[5] MartinsL M, IaccarinoI, TenevT, et al. . Theserine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem, 2002, 277: 439-439

[6] LeeS H, LeeJ W, KimH S, et al. . Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer. APMIS, 2003, 111: 586-586

[7] NieG Y, HamptonA, LiY, et al. . Identification and cloning of two isoforms of human HtrA3, characterisation of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2. Biochem J, 2003, 371: 39-39

[8] KevinR, McElenyR, WilliamG, et al. . Inhibitors of Apoptosis Proteins in Prostate Cancer Cell Lines. Prostate, 2002, 51: 133-133

[9] FaccioL, FuscoC, ChenA, et al. . Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem, 2000, 275: 2581-2581

[10] WittmannS, BaliP, DonapatyS, et al. . Flavopiridol Down-Regulates Antiapoptotic Proteins and Sensitizes Human Breast Cancer Cells to Epothilone B-induced Apoptosis. Cancer research, 2003, 63: 93-93